Analyst Research and Recommendations: Lattice Semiconductor Corporation (LSCC), AbbVie Inc. (ABBV)

Lattice Semiconductor Corporation (NASDAQ:LSCC) tinted gains of +0.63% (+0.05 points) to US$7.95. The volume of 0.67 Million shares climbed down over an trading activity of 1.13 Million shares. EPS ratio determined by looking at last 12 month figures is -0.21. Over the same time span, the stock marked US$8.9 as its best level and the lowest price reached was US$5.05. The corporation has a market cap of US$995.26 Million.

Lattice Semiconductor Corporation (NASDAQ:LSCC)’s earnings per share has been growing at a -17.9 percent rate over the past 5 year when average revenue increase was noted as 6.7 percent. The return on equity ratio or ROE stands at -11.1 percent while most common profitability ratio return on investment (ROI) was -9.3 percent. The company’s institutional ownership is monitored at 91.1 percent. The company’s net profit margin has achieved the current level of -6.6 percent and possesses 54.3 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 1 think it is Hold. Recently, analysts have updated the overall rating to 1.75. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

AbbVie Inc. (NYSE:ABBV) is worth US$127.79 Billion and has recently risen 0.63% to US$79.67. The latest exchange of 4.6 Million shares is below its average trading activity of 7.42 Million shares. The day began at US$79.11 but the price moved to US$78.9 at one point during the trading and finally capitulating to a session high of US$79.85. The stock tapped a 52-week high of US$122 while the mean 12-month price target for the shares is US$97.18.

Currently, the stock carries a price to earnings ratio of 15.69, a price to book ratio of 0, and a price to sales ratio of 3.97. For the past 5 years, the company’s revenue has grown 9%, while the company’s earnings per share has grown 1.2%. With an institutional ownership near 72.1%, it carries an earnings per share ratio of 5.08.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 3 brokerage firms polled by Factset Research. At present, 9 analysts recommended Holding these shares while 1 recommended sell, according to FactSet data. 2 analysts call it Underweight, while 3 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.72.